Skip to main content

GenoLogics Raises $5M in VC Round

NEW YORK (GenomeWeb News) – Victoria, BC-based GenoLogics has raised $5 million in a private round of financing with venture capital investors.

The bioinformatics firm said that proceeds would be used to fund its ongoing expansion plans and to accelerate development and global deployment of an end-to-end informatics solution for organizations pursuing translational research initiatives.

Seattle-based OVP Venture Partners led the round of financing with additional investment from Growth Works and Yaletown Venture Partners of Vancouver.

"We've already seen GenoLogics make significant inroads by establishing collaborative partnerships with leading organizations that are looking for ways to achieve their translational research outcomes," said Chad Waite, managing director at OVP, in a statement.

Filed under

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.